IBX 35.0% 5.4¢ imagion biosystems limited

Ann: FDA Breakthrough Device Designation, page-75

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 185 Posts.
    lightbulb Created with Sketch. 85
    it's not fundamental until you start realising value for the shareholder. sales and bottom line management (earnings)

    fundamental - yes, they have fda clearance.

    fundamental - yes, they have a weak balance sheet, including almost no equity and low cash.

    fundamental - just because they have FDA clearance doesn't mean they've proven their product to the market. sales and customer satisfaction will be the test

    just manage your expectations and remain fact based. if this was fundamental, you would be over 16m market cap.

    FDA is absolutely a step in the right direction. but people will speculate on this and trade it until the fundamentals are there.
    Last edited by slivering: 19/07/19
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.